STAT+: Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts
Aggressive state-level enforcement could dismantle drugmakers' data mandates, lowering compliance barriers for 340B covered entities while exposing pharmaceutical companies to state legal and regulatory liabilities.
STAT News·